X-linked inhibitor of apoptosis (XIAP) is the most potent member of the inhibitor of apoptosis protein (IAP) gene family in terms of its ability to inhibit caspases and suppress apoptosis. Recent evidence has suggested that XIAP is a key determinant in chemoresistance of cancer cells. To explore a novel approach for ameliorating chemotherapy of gastric cancer, the antisense expression vector for the XIAP gene was constructed and transferred into gastric cancer cell lines, MKN-45 (wild-type p53) and MKN-28 (mutant-type p53). This transfer resulted in significant downregulation of XIAP expression, decreased in vitro cell viabilities, and induced apoptosis. In transferred cells, inactive caspase-3 precursors were cleaved into the active subunits (p20 and p17) during apoptosis induced by downregulation of XIAP. The inhibitory effects of cisplatin and mitomycin C on the growth of XIAP downregulated cancer cells were significantly enhanced. In addition, this process occurred only in wild-type p53 (MKN-45), but not in mutant-type p53 (MKN-28) gastric cancer cells. The data presented suggest that downregulation of XIAP via antisense RNA can lead to apoptosis of gastric cancer cells in vitro, correlating with cellular p53 status and activation of caspase-3. This finding could lead to a potential strategy for improving the efficiency of therapies for gastric cancer.
G astric cancer is the most lethal cancer of the alimentary tract around the world. However, chemoresistance results in poor response rates in gastric cancer patients, making complete remission a rarity. It has been demonstrated that apoptosis is directly involved in death of tumor cells after treatment with chemotherapeutic agents or irradiation. The apoptotic process requires the activation of proteolytic enzymes termed caspases. Resistance to apoptosis provides the cancer cells with a survival advantage. Whether a cell continues through the cell cycle or undergoes apoptosis, in response to potential apoptotic stimuli, is controlled by a complex set of genes and proteins. Several potent endogenous proteins that inhibit apoptosis have been identified, including Bcl-2 and those grouped in inhibitor of apoptosis protein (IAP) families in mammalian cells. Xlinked inhibitor of apoptosis (XIAP) is the most potent member of the IAP gene family in terms of its ability to inhibit caspase and suppress apoptosis. 1 Overexpression of XIAP in cancer tissues and cell lines has been shown to suppress apoptosis induced by a variety of apoptotic stimuli, including tumor necrosis factor, Fas, serum or growth factor withdrawal, ischemia, and radiotherapy. 2 Apoptosis of cancer cells can be induced by antisense RNA that specifically targets antiapoptotic regulatory proteins. This has been identified as a potential strategy to improve therapeutic efficiency for cancer patients. Downregulation of XIAP via antisense technology has been successfully applied to induce cell death in granulosa cells, as well as to enhance the chemosensitivity of human ovarian cancer and non-small-cell lung cancer cells. 3 In this study, we utilized antisense RNA transfer via plasmid vector, and investigated the effects of downregulating XIAP expression on apoptosis and chemotherapeutic sensitivities of human gastric cancer cells in vitro, in the hope of defining a novel strategy for further therapy of gastric cancer.
Materials and methods

Antisense vector construction
The plasmid pEF-XIAP, containing the XIAP cDNA, was kindly provided by Dr David Vaux (Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute, Australia). Professor Shen Qu (Department of Biochemistry, Tongji Medical College, China) provided the eukaryotic vector pcDNA3.1. XbaI and BamHI (Promega Company, USA) digested the plasmids, pEF-XIAP and pcDNA3.1, to recover the XIAP gene (1.5 kb) and linear vector fragments (5.4 kb), respectively. The reverse ligation reaction was conducted with T 4 Ligase (Takara Company, Japan).
Gene transfer and expression
The human gastric cancer cell lines, MKN-45 (wild-type p53) and MKN-28 (mutant-type p53), were cultured in RPMI 1640 (Gibco PRL Company, USA), supplemented with 10% heat-inactivated fetal calf serum, 100 mg/ml streptomycin, and 100 IU/ml penicillin. Gene transfer was conducted with Lipofectamine 2000 (Gibco PRL Company, USA). Total RNAs were isolated from cells using Trizolt reagent (Gibco BRL Company, USA). RT-PCR amplification was conducted with the following primers:
0 . The extraction, quantification, and separation of proteins were conducted according to molecular cloning. Blots were evaluated using an ECL Western Blotting kit (Amersham Biosciences, USA). a-Tubulin served as an internal control.
Cell viability
Cells were seeded into triplicate wells in 24-well plates, at a density of 2 Â 10 5 viable cells per ml. After gene transfer for 1, 3, and 5 days, cancer cells were digested by 0.125% trypsin and 0.01% EDTA, stained with trypan blue and counted under an inversion microscope. The in vitro cell growth curve was drawn.
Cellular morphological observation
Cancer cells were collected, rinsed with phosphate-buffer saline (PBS), fixed using 2.5% glutaraldehyde for 30 minutes, and then washed with PBS. After routine embedment and slicing, cellular ultrastructure was observed under an electronic microscope. The TdT-mediated dUTP-biotin nick end labeling (TUNEL, Promega Company, USA) kit was applied to detect the apoptotic cells.
Cellular apoptosis detection
Cells were collected, washed twice with 0.01 mol/L PBS and fixed in 70% ethanol overnight at 41C. Then, cells were washed once with PBS, digested by 200 ml of RNase (1 mg/ml) at 371C for 30 minutes, and stained with 800 ml of propidium iodide (50 mg/ml) at room temperature for 30 minutes. The DNA histograms were assayed by flow cytometry (Becton Dickson Company, USA), using CELLQUEST software.
Caspase-3 expression and activities assays
Determinations of cellular caspase-3 expression came from Western blotting. The activities of caspase-3 were detected using a colorimetric assay kit (Alexis Biochemicals, USA). The optical density A values (A 405 nm ) of the slides, which stand for activities of caspase-3, were read on an enzymelabeled Minireader II at a wavelength of 405 nm.
Chemotherapeutic sensitivities assay
Cisplatin (DDP) and mitomycin C (MMC) were purchased from Sigma Chemical Company (USA). After gene transfer for 3 days, cancer cells were incubated with DDP (1, 5, 10 mg/ml) and MMC (0.1, 1, 10 mg/ml) for 24 hours, respectively. The 3, [4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) colorimetric method was used to detect cellular chemotherapeutic sensitivities. The optical density A values (A 570 nm ) of the slides were read on an enzyme-labeled Minireader II at a wavelength of 570 nm. Inhibitory rates of cell proliferation were calculated as (%) ¼ (1Àaverage A 570 nm value of experimental group/average A 570 nm value of untransferred control) Â 100%.
Statistical analysis
Data were expressed as mean7SD. The statistical significance of findings was determined via Student's ttest and analysis of variance (ANOVA) using the SPSS 10.0 statistical software. Po.05 was considered significant.
Results
Downregulation of XIAP expression in gastric cancer cells
To downregulate cellular XIAP expression, we first constructed the antisense vector for XIAP, pcDNA-AS-XIAP (6.9 kb) . We then transferred this recombinant into both gastric cancer cell lines and measured the XIAP expression. RT-PCR and imaging analysis (Gel Doc 1000 computer system) indicated that XIAP/a-tubulin ratios in antisense XIAP-transferred MKN-45 cells were significantly reduced over those of untransferred cells (0. 
Cell viability inhibition
Since it has been demonstrated that XIAP plays an 
Cellular apoptosis induced
Previous studies have shown that downregulation of XIAP via antisense RNA induced apoptosis in human ovarian cancer cells. Presently, we examined whether downregulation of XIAP could also induce apoptosis of gastric cancer cells. Morphological observation under an electronic microscope indicated that after antisense XIAP transfer, parietal MKN-45 presented characteristic changes associated with apoptosis, such as nuclear shrinkage, chromatin congregation around the nuclear membrane, reduction of cell volume, and integrity of nuclear membrane. However, there were no such morphological alternations in antisense XIAP-transferred MKN-28 cells. After being cultured for 3 days, the TUNEL assay indicated that the apoptotic rates of untransferred MKN-45 and MKN-28 cells were 4.771.0 and 4.270.8%, respectively. At 3 days after antisense XIAP transfer, the apoptotic rates of MKN-45 cells were significantly increased than those of MKN-28 cells (26.873.4 vs 6.171.2%, P ¼ .002).
Apoptosis rates detection
To further investigate the apoptotic rates induced by downregulation of XIAP, we applied a flow cytometry assay. There was no obvious subdiploid DNA peak, which corresponded to the apoptotic cell fraction, in untransferred, blank vector-transferred or antisense XIAP-transferred MKN-28 cells (Fig 1) . The number of apoptotic cells was increased in the antisense XIAPtransferred MKN-45 cells, and the apoptotic rates were significantly higher than those of untransferred (24.472.6 vs 2.870.4%, P ¼ .001) and blank vector-transferred (24.472.6 vs 3.470.7%, P ¼ .004) cells.
Caspase-3 activation
Next, we evaluated the effects of downregulating XIAP expression on activities of casapse-3 in MKN-45 and MKN-28 cells. After antisense XIAP transfer, the 20 kDa and 17 kDa protein bands, corresponding to the p20 and p17 subunits of caspase-3, could be detected in MKN-45 but not in MKN-28 cells. The A 405 nm values, standing for activities of caspase-3, showed no significant difference between MKN-45 and MKN-28 cells. However, after antisense XIAP transfer for 3 d, their A 405 nm values were 0.26470.010 and 0.05270.011 respectively, which were significantly different (P ¼ .034).
Enhanced chemotherapeutic sensitivities
Growing evidence suggests that XIAP is correlated with chemoresistance of cancer cells. Hence, we examined the chemotherapeutic sensitivities of cancer cells after downregulation of XIAP. As shown in Figure 2 , treatment with DDP (1, 5, 10 mg/ml) and MMC (0.1, 1, 10 mg/ml) for 24 hours could result in a decrease in growth activities of untransferred MKN-45 cells in a dose-dependent manner. At 3 days after antisense XIAP transfer, the growth inhibitory rates of DDP (24. 
Discussion
Owing to the negative side effects associated with chemotherapeutic drugs on normal cells and the possibility of tumor cells becoming chemoresistant, it has been a research focus on how to ameliorate the chemotherapeutic effects of gastric cancer. Recent findings indicate that abnormal suppression of apoptosis is an important factor during occurrence and development of cancer. If apoptotic repair can be accomplished, perhaps the sensitivities of tumor cells to chemotherapeutic drugs could be improved, and chemoresistance could be overcome. 4 The mechanisms of apoptosis are highly conserved in a plethora of species and they include a series of processes. Usually, apoptosis can be divided into three distinct phases: the initiation, the effector, and the execution phase. When outer stimuli initiate cellular apoptosis by different pathways, including death receptor-mediated and stress-dependent triggers, the imbalance between activators and inhibitors of apoptosis appears. After initiation, the activated caspases family and changes in mitochondrial outer membrane permeability finally result in cellular apoptosis. 5 The IAP family, originally identified in baculovirus, can suppress apoptotic process by inhibiting procaspase activation and the catalytic activity of mature caspases. 6 The IAPs have been postulated to contribute to the development of some cancers. One example is a postulated causal chromosomal translocation involving cIAP2/ HIAP1 that has been identified in MALT lymphoma. 7 As an important member of IAP family, XIAP suppresses apoptosis via inhibition on caspase-3 and -7. A recent correlation between elevated XIAP and poor prognosis along with short survival has been demonstrated in patients with acute myelogenous leukemia. 8 XIAP is highly overexpressed in many tumor cell lines of the NCI (NIH) panel 9 ; however, there is little direct evidence about the role XIAP plays in tumor initiation, growth, metastasis, and chemoresistance of gastric cancer.
In the present study, downregulation of XIAP expression was induced in the gastric cancer cell lines MKN-45 and MKN-28. It was also indicated that downregulation of XIAP could induce apoptosis and enhance chemotherapeutic sensitivities in gastric cancer cells (Figs 1 and 2) . Current evidence indicates that the caspases, which are cysteine proteases of the ICE/CED-3 family, are the central components of the cell death machinery in various forms of apoptosis. Moreover, caspase-3 is the most likely candidate for a mammalian cell death regulator because it cleaves vital cellular proteins. In this study, we found that the inactive caspase-3 precursors were cleaved into the 20 and 17 kDa subunits, forming the active protease, during apoptosis induced by downregulation of XIAP. In addition, this process was correlated with cellular p53 status, because induction of apoptosis occurred only in cells with wild-type p53 (MKN-45), but not in those cells with mutant-type p53 (MKN-28). Sasaki et al 10 demonstrated that in addition to its well-established inhibitory action on caspase-3 activity, XIAP appears to be central in the control of p53 accumulation and p53-mediated apoptosis, possibly via the MDM2-p53-ubiquitin degradation pathway. In mutant-type p53 cancer cells, coexpression of antisense XIAP and wild-type p53 sense was more effective than wild-type p53 restoration alone. This observation implies that treatment of wild-type p53 cancer cells with antisense XIAP gene transfer might be possible.
In conclusion, the data presented in this paper show for the first time that downregulation of XIAP, mediated by antisense RNA vectors, leads to apoptosis and enhancement of chemotherapeutic sensitivities in gastric cancer cells in vitro. Furthermore, apoptosis induced by downregulation of XIAP correlates with p53 status and activation of caspase-3. Consistent with other findings regarding the XIAP gene, we believe that XIAP plays a pivotal role in the process of apoptosis. These results provide a new concept for development of novel therapeutic approaches for gastric cancer. Studies with xenograft models are required to establish whether these strategies are indeed applicable in vivo.
